Shell Company. The Company is not an “ineligible issuer” (as defined in Rule 405 promulgated under the Securities Act) and is not, and has never been, an issuer identified in, or subject to, Rule 144(i)(1) of the Securities Act.
Appears in 6 contracts
Sources: Securities Purchase Agreement (Rubric Capital Management LP), Securities Purchase Agreement (Eloxx Pharmaceuticals, Inc.), Securities Purchase Agreement (Heron Therapeutics, Inc. /De/)
Shell Company. The Company is not an “ineligible issuer” (as defined in Rule 405 promulgated under the Securities Act) and is not, and has never been, an issuer identified in, or subject to, Rule 144(i)(1) of the Securities Act.. (mm)
Appears in 1 contract
Sources: Securities Purchase Agreement (Heron Therapeutics, Inc. /De/)